Offer - Urjas Oil for just ₹ 1 X
Kofarest Ls is a prescription drug, available for use as Syrup. Kofarest Ls also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Kofarest Ls. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Kofarest Ls are Constipation, Heartburn, Nausea or vomiting. Besides the aforementioned side effects, there are other adverse effects of Kofarest Ls as well, which are listed below. These side effects of Kofarest Ls are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Kofarest Ls's effect during pregnancy is Moderate and Moderate while nursing. It is important to know if Kofarest Ls has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Kofarest Ls related warnings section.
Kofarest Ls is contraindicated in people with pre-existing medical conditions like Gastrointestinal Bleeding, Asthma, Smoking Addiction as it can result in adverse effects. Other conditions have been mentioned below in the Kofarest Ls contraindications section.
Drug reaction of Kofarest Ls with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Kofarest Ls is safe while driving, and is is addictive in nature.
Kofarest Ls is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Kofarest Ls safe for pregnant women?
Kofarest LS may have some side effects during pregnancy. Pregnant women should discontinue the use of Kofarest LS, and talk to their doctor, if they notice any discomfort.
Is the use of Kofarest Ls safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Kofarest LS. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Kofarest Ls on the Kidneys?
Kofarest LS may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Kofarest Ls on the Liver?
The liver can be affected by Kofarest LS. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Kofarest LS only after medical advice.
What is the effect of Kofarest Ls on the Heart?
Kofarest LS can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Kofarest Ls should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Kofarest Ls unless your doctor advises you to do so -
Is this Kofarest Ls habit forming or addictive?
Kofarest Ls is not addictive in nature.
Interaction between Food and Kofarest Ls
There is no information on the effects of taking Kofarest Ls with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Kofarest Ls
Consumption of alcohol and Kofarest Ls together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Guaifenesin
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 629-631
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 888
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1182-1183